Palliation of Multiple Bone Metastases from Prostatic Carcinoma with Strontium-89

Authors

  • J. Tennvall Departments of Oncology, Radiation Physics, and Urology, University Hospital, S-22185, Lund, Sweden
  • L. Darte Departments of Oncology, Radiation Physics, and Urology, University Hospital, S-22185, Lund, Sweden
  • R. Lundgren Departments of Oncology, Radiation Physics, and Urology, University Hospital, S-22185, Lund, Sweden
  • A. Mohamed El Hassan Departments of Oncology, Radiation Physics, and Urology, University Hospital, S-22185, Lund, Sweden

DOI:

https://doi.org/10.3109/02841868809093556

Keywords:

Prostate cancer; bone metastases, 89Sr treatment

Abstract

The efficacy of strontium-89 in relieving pain caused by disseminated bone metastases was studied in 11 patients with prostatic carcinoma. The therapy consisted either of 3 i.v. injections of 100 MBq strontium-89 chloride in intervals of 4 weeks in 8 patients or 200 MBq i.v. administered on one occasion in 3 patients. The study suggests that 1–3 i.v. injections of 100 MBq strontium-89 may be a worthwhile and fairly atoxic treatment for palliation of bone pain from metastatic prostatic carcinoma.

Downloads

Download data is not yet available.

Downloads

Published

1988-01-01

How to Cite

Tennvall, J., Darte, L., Lundgren, R., & Mohamed El Hassan, A. (1988). Palliation of Multiple Bone Metastases from Prostatic Carcinoma with Strontium-89. Acta Oncologica, 27(4), 365–369. https://doi.org/10.3109/02841868809093556

Issue

Vol. 27 No. 4 (1988): Acta Oncologica

Section

Articles